A pilot project, led by the City of Hamilton and involving McMaster University and AllerGen partner Anaphylaxis Canada, is being launched today (September 8, 2014) in Hamilton. The project will analyze the effects of stocking epinephrine auto-injectors at Jackson Square …
Allergy researchers at The University of British Columbia (UBC) have found that antibiotic use in early life alters gut bacteria and enhances future susceptibility to inflammatory lung disease. The study, led by AllerGen investigator Dr. Kelly McNagny, a professor in …
A new study by AllerGen researchers has shown that children treated with antibiotics in the first year of life are more than twice as likely to be overweight later in childhood compared to children who were unexposed. The study, published …
New study links antibiotic use to overweight in children Read more »
Dr. Michael Brauer, an AllerGen investigator and a professor in the School of Population and Public Health at The University of British Columbia (UBC), is leading a new study that will provide an unparalleled worldwide analysis of the relationship between …
AllerGen researcher funded to lead worldwide study of air pollution and disease Read more »
An AllerGen investigator is among 90 Canadians named in Thomson Reuters’ new compilation of “The World’s Most Influential Scientific Minds: 2014.” Dr. Fiona Brinkman, a professor in the Department of Molecular Biology and Biochemistry at Simon Fraser University, was ranked …
AllerGen investigator chosen for 2014 “World’s Most Influential Scientific Minds” Read more »
AllerGen investigator Dr. Kelly McNagny (The University of British Columbia) is co-editor of a new edition of Mast Cells: Methods and Protocols, a volume in the Methods in Molecular Biology series published by Humana Press. The text is intended for …
Network members contribute to new volume on the study of mast cells Read more »
Researchers in AllerGen’s Clinical Investigator Collaborative (CIC) have shown that a new drug (quilizumab) successfully blocks the production of an immune system protein, reducing symptoms of allergic asthma. The study, led by Dr. Gail Gauvreau (McMaster University), was conducted by …
CIC investigators test new drug for allergic asthma Read more »
A new study by AllerGen researchers reveals that low-income families affected by food allergies felt “unsafe” procuring allergen-free foods at food banks and discount supermarkets, may be misinformed the social assistance health insurance plan, and distanced themselves from other low-income …
Low income, high risk: the overlapping stigmas of food allergy and poverty Read more »
Anaphylaxis Canada’s “Allergy Pals,” an online peer support and mentorship program for children with severe food allergies, was recently profiled by Global TV News (Edmonton). Dr. Miriam Stewart and a team from the University of Alberta developed the mentoring program …
Researchers at AllerGen’s Clinical Investigator Collaborative (CIC) have discovered that an antibody can block a specific protein in the lungs and reduce the symptoms of inflammation and bronchoconstriction experienced by people with mild allergic asthma. The study, published in the …
CIC investigators publish new findings for allergic asthma Read more »
Dr. Michael Brauer, a Professor at the School of Population and Public Health, The University of British Columbia, and an AllerGen Principal Investigator, has been named as the first recipient of the Asthma Society of Canada’s Bastable-Potts Asthma Research Prize. …
Dr. Michael Brauer honoured for research on asthma and the environment Read more »
Anaphylaxis Canada has launched Allergy Pals, an online mentorship program designed to provide peer support and mentoring to children (ages 7-11) affected by severe food allergies. Allergy Pals offers eight online support sessions led by older peer mentors with food …
Allergy Pals – Online Mentorship for Kids with Food Allergies Read more »